PTMA and alkaline phosphatase measurement: Furthermore, the downregulation of HLA-DR and alterations in the Kynurenine pathway, which have been linked to the onset of IPN during AP (8), and treatments like thymosin alpha 1, aimed at enhancing immunity, show potential in reducing the occurrence of IPN in AP patients (9).